Farnaz Poorhasan: FFP is More Than Just Frozen Blood Components
Farnaz Poorhasan, Laboratory Technician at Niloo Lab, shared a post on LinkedIn:
“FFP: More Than Just a Frozen Blood Component.
This image shows units of Fresh Frozen Plasma (FFP) stored in a blood bank freezer. More than just a frozen blood component, FFP plays a critical role in modern transfusion medicine-one that continues to evolve with emerging evidence and updated clinical guidelines.
According to current AABB recommendations:
Key takeaways about FFP:
- Routine or prophylactic plasma transfusion is generally not recommended.
- An abnormal coagulation test (e.g., INR) alone is not a sufficient indication for plasma transfusion.
- FFP should not be used for volume expansion.
- Plasma transfusion decisions should be guided by the patient’s clinical condition, particularly in the presence of active bleeding or before an invasive procedure when clinically significant coagulopathy is present.
- Patient Blood Management (PBM) emphasizes using the right blood component, for the right patient, at the right time, and for the right indication.
Every unit of FFP represents a valuable and limited resource.
Evidence-based transfusion practices not only improve patient outcomes but also reduce unnecessary transfusions and their associated risks.
Reference: AABB Clinical Practice Guidelines for Plasma Transfusion and Patient Blood Management (PBM).”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 12:46Andrew Choong: Recognizing Thrombosis Before It Becomes Life-Threatening
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval
-
Oct 19, 2026, 10:28Brig Tathagata Chatterjee: Acute Leukemias in AYAs at the Japanese Society of Hematology Conference
-
Oct 19, 2026, 10:27Heather M. Johnson: Join the Discussion on Optimizing the CTEPH Diagnostic Pathway
-
Oct 19, 2026, 10:18Flora Peyvandi: Unravelling the Complexity of VWF Through Genetics